Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer - Concepedia

Concepedia

Publication | Open Access

Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

DOI Full Paper Access

79

Citations

19

References

2009

Year

Michael Teneriello, Paul C. Tseng, Mark Crozier, Carlos A. Encarnacion, Kenneth C. Hancock, Mark Messing, Kristi A. Boehm, Alicia Williams, Lina Asmar

Journal of Clinical Oncology

Abstract

Nab-paclitaxel is active in this group of patients with recurrent ovarian, peritoneal, or fallopian tube cancer. The ORR was 64%. Toxicities were manageable. Further studies of nab-paclitaxel in combination with platinum are warranted.

References

	Year	Citations

Page 1